Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value and Safety of EBUS-TBNA Combined With Medaistinal Cryobiopsy for Mediastinal Metastasis of Lung Cancer

NCT07488507 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT07488507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07488507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value and Safety of EBUS-TBNA Combined With Medaistinal Cryobiopsy for Mediastinal Metastasis of Lung Cancer
Lead sponsor
Third Military Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
March 20, 2026
Completion date
March 1, 2030
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mediastinal metastases of lung cancer